Бастиан Блоэм - Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

6. The Cure Parkinson’s Trust and Parkinson’s community mourn the loss of their champion Tom Isaacs. Cure Parkinson’s Trust. June 19, 2017. www.cureparkinsons.org.uk/news/cpt-pd-community-mourns-the-loss. Accessed March 14, 2019.

7. Там же.; Tom Isaacs memorial. World Parkinson Coalition. www. worldpdcoalition.org/page/ TomIsaacs. Accessed March 27, 2019.

8. Grisales C. Veterans, families demand that EPA ban toxic chemical found in tap water at US military bases. Stars and Stripes. August 1, 2018. www.stripes.com/news/veterans-families-demand-that-epa-ban-toxic-chemical-found-in-tap-water-at-us-military-bases-1.540501. Accessed February 11, 2019.

9. Там же.

10. Returning EPA to its core mission. US Environmental Protection Agency. www.epa.gov/home/returning-epa-its-core-mission. Updated July 6, 2018. Accessed March 27, 2019.

11. Falce A. Congress increases research funding, shows support for care partners. FoxFeed Blog. September 28, 2018. www.michaeljfox.org/news/ congress-increases-research-funding-shows-support-care-partners. Accessed June 28, 2019.

12. Intel co-founder Andrew S. Grove dedicates portion of his estate, up to $40 million, to Michael J. Fox Foundation [пресс-релиз]. The Michael J. Fox Foundation. January 10, 2008. www.michaeljfox.org/publication/ intel-co-founder-andrew-s-grove-dedicates-portion-his-estate-40-million-michael-j-fox. Accessed June 28, 2019.

13. Reuters. Intel pioneer and Holocaust survivor Andy Grove dies at 79. Haaretz. March 22, 2016. www.haaretz.com/jewish/intel-pioneer-and – holocaust-survivor-andy-grove-dies-at-79-1.5421022. Accessed March 27, 2019; Newton C. Legendary former Intel CEO Andy Grove is dead at 79. The Verge. March 21, 2016. www.theverge. com/2016/3/21/11280004/andy-grove-intel-ceo-dies. Accessed March 27, 2019.

14. Andrew Grove. Wikipedia. https://en.wikipedia.org/wiki/Andrew_ Grove. Updated February 10, 2019. Accessed February 11, 2019.

15. Dolan KA. Andy Grove’s last stand. Forbes. January 11, 2008. www. forbes.com/forbes/ 2008/0128/070.html#462dbe0b641e. Accessed June

28, 2019.

16. Там же.

17. Pollack A, Levy J. The New York Times: Andy Grove’s prescription for health care. FoxFeed Blog. November 18, 2009. www.michaeljfox.org/ news/new-york-times-andy-groves-prescription-health-care. Accessed June 28, 2019.

18. Olavsrud T. Intel turns to wearables, big data to fight Parkinson’s. CIO.com. October 28, 2014. www.cio.com/article/2839555/intel-turns-to-wearables-big-data-to-fight-parkinsons.html. Accessed March 28, 2019; Ungerleider N. Why Intel and The Michael J. Fox Foundation are teaming up to create wearable tech for Parkinson’s. Fast Company. August 15, 2014. www.fastcompany.com/3034433/why-intel-and-the-michael-j-fox-foundation-are-teaming-up-to-create-wearable-tech-for-parkin. Accessed March 28, 2019.

19. Andy Grove: we remember six key facts about the former Intel CEO and visionary. NexChange. 2016. https://nexchange.com/article/9009. Accessed March 28, 2019.

20. McGregor J. This moving tribute explains why former Intel CEO Andy Grove was revered by so many. Washington Post. March 22, 2016. www. washingtonpost.com/news/on-leadership/wp/2016/03/22/this-moving-tribute-explains-why-former-intel-ceo-andy-grove-was-so-revered-by-so-many/?noredirect=on&utm_term=.3ba0dee8f248. Accessed June 28, 2019.

21. Goetz CG, Stebbins GT, Wolff D, et al. Testing objective measures of motor impairment in early Parkinson’s disease: feasibility study of an at-home testing device. Movement Disorders. 2009;24(4):551–556.

22. Shinal J. Andy Grove remembered as “bridge builder.” USA Today. June 20, 2016.

23. Michael J. Fox Foundation for Parkinson’s Research. Tuck School of Business at Dartmouth. http://mytuck.dartmouth.edu/show_module_ fw2.aspx?sid=1353&gid=5&control_id=11858&nologo=1&cvprint=1&p age_id=4475&crid=0&viewas=user. Accessed March 28, 2019.

24. Teichholtz H. The Michael J. Fox Foundation mourns passing of Andy Grove. FoxFeed Blog. March 22, 2016. www.michaeljfox.org/news/ michael-j-fox-foundation-mourns-passing-andy-grove. Accessed June 28, 2019.

25. McGregor J. This moving tribute explains why former Intel CEO Andy Grove was revered by so many. Washington Post. March 22, 2016. www. washingtonpost.com/news/on-leadership/wp/2016/03/22/this-moving-tribute-explains-why-former-intel-ceo-andy-grove-was-so-revered-by-so-many/?noredirect=on&utm_term=.3ba0dee8f248. Accessed June 28, 2019; Program information. Andy Grove Scholarship for Intel Employees’ Children. www.scholarsapply.org/intel/instructions.php. Accessed March 28, 2019; Burgelman R, Meza P. Grove Scholars Program: putting rungs back on the ladder. Stanford Graduate School of Business. 2005. www. gsb.stanford.edu/faculty-research/case-studies/grove-scholars-program-putting-rungs-back-ladder. Accessed March 28, 2019; City College mourns distinguished alumnus Andrew Grove ’60. City College of New York. March 22, 2016. www.ccny.cuny.edu/ news/city– college-mourns – distinguished-alumnus-andrew-grove-%E2%80%9960. Accessed March 28, 2019.

26. Kaiser J. Final 2018 budget bill eases biomedical researchers’ policy worries. Science. March 22, 2018. American Association for the Advancement of Science. www.sciencemag.org/news/ 2018/03/ final-2018-budget-bill-eases-biomedical-researchers-policy-worries. Accessed June 27, 2019.

27. Estimates of funding for various research, condition, and disease categories (RCDC). National Institutes of Health. 2018. https://report. nih.gov/categorical_spending.aspx. Updated May 18, 2018. Accessed March 31, 2019; Biomedical Research and Development Price Index. Bureau of Economic Analysis. 2018. https://officeoffiudget.od.nih.gov/ gbipriceindexes.html. Updated January 2018. Accessed October 15, 2018.

28. Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. npj Parkinsons Disease. 2018;4(1):21.

29. Estimates of funding for various research, condition, and disease categories (RCDC). National Institutes of Health. 2018. https://report. nih.gov/categorical_spending.aspx. Updated May 18, 2018. Accessed March 31, 2019; Biomedical Research and Development Price Index. Bureau of Economic Analysis. 2018. https://officeofbudget.od.nih.gov/ gbipriceindexes.html. Updated January 2018. Accessed October 15, 2018; Marras C, Beck JC, Bower JH, et al. Prevalence of Parkinson’s disease across North America. npj Parkinson’s Disease. 2018;4(1):21.

30. Chun D. First sign of Parkinson’s hit Fox during filming. Gainesville Sun. May 15, 2009. www.gainesville.com/news/20090515/first-sign-of-parkinsons-hit-fox-during-filming. Accessed March 28, 2019.

31. Raffalli M. Michael J. Fox: working towards cure for Parkinson’s “one of the great gifts of my life.” CBS News. July 8, 2018. www.cbsnews.com/ news/michael-j-fox-working-towards-cure-for-parkinsons-one-of-the-great-giftsof-my-life. Accessed March 28, 2019.

32. IRS Form 990. The Breast Cancer Research Foundation Inc. 2016. https://

projects.propublica.org/nonprofits/display_990/133727250/2017_03_ EO%2F13-3727250_990_201606; IRS Form 990. Alzheimer’s Disease & Related Disorders Association, Inc. 2016. www.alz.org/media/ Documents/form-990-fy-2017.pdf; IRS Form 990. JDRF International. 2016. https://1x5°5mujiug388ttap1p8s17-wpengine.netdna-ssl.com/wp-content/uploads/2018/01/JDRF-FY2017-990-Tax-Return.pdf; IRS Form 990, Arthritis Foundation Inc. 2016. www.arthritis.org/Documents/ Sections/About-Us/2016-National-Office-990.pdf; IRS Form 990. The Michael J. Fox Foundation for Parkinson’s Research. 2016. https:// files.michaeljfox.org/2016-990-MJFF.pdf.

33. Nocera J. The Michael J. Fox Foundation gets results: the latest treatment for Parkinson’s disease was made possible by the actor’s audacious mission. Bloomberg. January 23, 2019. www.bloomberg.com/opinion/ articles/2019-01-23/parkinson-s-inhaler-the-michael-j-fox-foundation-gets-results. Accessed February 11, 2019.

34. Patel AB, Jimenez-Shahed J. Profile of inhaled levodopa and its potential in the treatment of Parkinson’s disease: evidence to date. Neuropsychiatric Disease and Treatment. 2018;14:2955–2964.

35. King S. Pink Ribbons, Inc.: Breast Cancer and the Politics of Philanthropy. 1st ed. University of Minnesota Press; 2008.

36. Tanner CM, Kamel F, Ross GW, et al. Rotenone, paraquat, and Parkinson’s disease. Environmental Health Perspectives. 2011;119(6):866-

872; Goldman SM, Quinlan PJ, Ross GW, et al. Solvent exposures and Parkinson disease risk in twins. Annals of Neurology. 2012;71(6):776–784; Tanner CM, Ottman R, Goldman SM, et al. Parkinson disease in twins: an etiologic study. JAMA. 1999;281(4):341–346.

37. Kuhl MM. New $6 million program looks at causes of Parkinson’s. FoxFeed Blog. March 22, 2018. www.michaeljfox.org/news/new-6-million-program-looks-causes-parkinsons. Accessed June 28, 2019.

38. State Cancer Profiles. https://statecancerprofiles.cancer.gov. Accessed March 28, 2019.

39. Strickland D, Bertoni JM. Parkinson’s prevalence estimated by a state registry. Movement Disorders. 2004;19(3):318–323; Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34(3):143–151.

40. Parkinson Disease Registry. Utah Department of Health. 2018. www. updr.org. Accessed January 4, 2019; Parkinson’s Disease Registry. Nebraska Department of Health & Human Services. 2015. http:// dhhs.ne.gov/publichealth/Pages/ced_parkinsons_index.aspx. Updated February 7, 2018. Accessed January 4, 2019.

41. Tanner CM. California’s Parkinson’s Disease Registry pilot project– coordination center and Northern California ascertainment. Defense Technical Information Center. March 2014. https://apps.dtic.mil/dtic/tr/ fulltext/u2/a601866.pdf. Accessed June 28, 2019.

42. California Parkinson’s Disease Registry. California Department of Public Health. Chronic Disease Surveillance and Research Branch (CDSRB). www.cdph.ca.gov/Programs/ CCDPHP/DCDIC/CDSRB/Pages/California-Parkinson%27s-Disease-Registry.aspx. Updated October 1, 2018. Accessed October 15, 2018.

43. Parkinson Disease Registry. Utah Department of Health. 2018. www. updr.org. Accessed January 4, 2019; Parkinson’s Disease Registry. Nebraska Department of Health & Human Services. 2015. http:// dhhs.ne.gov/publichealth/Pages/ced_parkinsons_index.aspx. Updated February 7, 2018. Accessed January 4, 2019.

44. Strickland D, Bertoni JM. Parkinson’s prevalence estimated by a state registry. Movement Disorders. 2004;19(3):318–323.

45. GBD 2016 Parkinson’s Disease Collaborators. Global, regional, and national burden of Parkinson’s disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurology. 2018;17(11):939–953.

46. Singleton AB, Farrer M, Johnson J, et al. a-synuclein locus triplication causes Parkinson’s disease. Science. 2003;302(5646):841–841.

47. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson’s disease. Neuron. 2004;44(4):595–600.

48. Farrer MJ. Genetics of Parkinson disease: paradigm shifts and future prospects. Nature Reviews Genetics. 2006;7(4):306–318; Simon-Sanchez J, Schulte C, Bras JM, et al. Genome-wide association study reveals genetic risk underlying Parkinson’s disease. Nature Genetics . 2009;41:1308; Dawson TM, Ko HS, Dawson VL. Genetic animal models of Parkinson’s disease. Neuron. 2010;66(5):646–661; Singleton AB, Hardy JA, Gasser T. The birth of the modern era of Parkinson’s disease genetics. Journal of Parkinsons Disease. 2017;7(Suppl 1):S87-S93.